Aeterna Zentaris enters exclusive agreement

Aeterna Zentaris Inc. (Nasdaq: AEZS) entered an exclusive license agreement for Cyntec to commercialize Zoptrex in Taiwan and nine Southeast Asian countries. The stock price gained 35 cents to close at $3.61.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.